期刊文献+

吸人糖皮质激素对哮喘患者外周血CD_(34)^+细胞、IL-5和嗜酸粒细胞的影响 被引量:2

The Effects of G lucocorticoids on CD_(34)^+ cell,I nterleukin-5 and Eosinophils in the Peripheral Blood of Asthma Patients
下载PDF
导出
摘要 目的:探讨糖皮质激素对支气管哮喘患者外周血CD_(34)^+细胞、白细胞介素-5(IL-5)和嗜酸粒细胞(EOS)的影响。方法:选择哮喘急性发作期患者30例,常规取血测定CD_(34)^+细胞、IL—5和EOS;用吸入治疗2周后,再次取血测定外周血EOS计数、IL—5水平及CD_(34)^+细胞数目。结果:哮喘患者外周血EOS、IL-5及CD_(34)^+细胞数明显高于正常组(P<0.01)EOS凋亡指数呈显著下降( P<0.01)。经吸入布地奈德治疗2周后,IL-5、EOS及CD_(34)^+水平均显著降低。EOS凋亡指数呈显著增加,哮喘患者血清IL-5水平与EOS数呈显著正相关(r=0.92,P<0.01),与CD_(34)^+细胞数亦呈显著正相关(r=0.90,P<0.01)。结论:糖皮质激素可能影响CD_(34) ^+造血细胞的释放和向外周组织的迁移。 Objective: To study the effects of glucocorticoids on CD34^ + cell ,interleukin-5 (IL-5) and eosinophils(EOS) in the peripheral blood of asthma patients. Methods:46 asthmatic cases were treated by inhalation of glucocorticoids (Budesonide) for two weeks. The numbers of EOS and CD34^+ cells were counted and the level of IL-5 and EOS apoptotic index (AI) in the peripheral blood were measured. Results:The amount of EOS and CD34^ + cells and the level of IL-5 in the peripheral blood of the asthma patients were significandy higher than those of normal control ( P 〈 0.01) ,but the apoptotic index (AI)was lower .After 2 weeks of treatment, The amount of EOS and CD34^+ cells and the level of IL-5 decreased signiticandy ,while the apoptotic index (AI) increased signiticandy ( P 〈 0.01). The level of IL-5 was positivdy related to the amount of EOS ( r =0.92, P 〈 0.01),as well as to the amount of CD34^+ cells ( r = 0.90, P 〈 0.01).Conclusion:Glucocorticoids might affect release and emigration outwards to peripheral tissues of CD34 + cells in the peripheral blood of asthmatic patients .
出处 《现代生物医学进展》 CAS 2007年第5期737-738,744,共3页 Progress in Modern Biomedicine
关键词 支气管哮喘 CD34+细胞 IL-5 嗜酸粒细胞 糖皮质激素 Asthma CD34^+ cell Interleukin-5 Eosinophils Glucocorticoids
  • 相关文献

二级参考文献10

  • 1GibsonPG,DolovichJ,GirgisGabarboA etal.Theinflammationresponseofasthmaexacerbation:changesincirculationeosinophils basophilsandtheirprogenitors[].ClinExpAllergy.1990
  • 2KungTT,SteltsDM,ZurcherZ etal.InvolvementofIL 5inamurinemodelofallergicpulmonaryinflammationprophylacticandtherapeuticeffectofanantiIL 5antibody[].AmJRespirCellMolBiol.1995
  • 3SehmiR,WoodLJ,WatsonR ,etal.Allergy inducedincreasesinIL 5receptoralpha subunitexpressiononbonemarrow derivedCD34+ cellsfromasthmaticsubjects:anovelmarkerofprogenitorcellcommitmenttowardseosinophilicdifferentiation[].The Journal of Clinical Investigation.1997
  • 4HamidQ,BarkansJ,MengQ etal.Humaneosinophilssynthesizeandsecretinterleukin6 invitro[].Blood.1992
  • 5InmanMD.Bonemarroweventsinanimalmodelsofallergicinflammationandhyperresponsiveness[].The Journal of Allergy and Clinical Immunology.2000
  • 6TomakiM,ZhaoLL,LundalhJ etal.Eosinophilopoiesisinamurinemodelofallergicairwayeosinophilia:involvementofbonemarrowIL 5andIL 5receptorα[].JImmunol.2000
  • 7AalbersR,KauffmanHF,VrugtB etal.Allergyinducedrecruitmentofinflammatorycellsinlavage3and24hafterchallengedinasthmaticlungs[].Chest.1993
  • 8RobinsonDS,DamiaR,ZeibecoglouK etal.CD34+/IL 5RαmessengerRNA +cellsinthebronchialmucosainasthma:potentialairwayeosinophilprogenitors[].AmJRespirCellMolBiol.1999
  • 9CameronL,ChristodoulopoulosP,LavigneF etal.Evidenceforlocaleosinophildifferentiationwithinallergicnasalmucosa:inhibitorwithsolubleIL 5receptor[].JImmunol.2000
  • 10Hogan MB,Piktel MD,Landreth KS.IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma[].The Journal of Allergy and Clinical Immunology.2000

共引文献4

同被引文献27

  • 1Strek ME. Difficult asthma. Proc Am Thorac Soc, 2006,3(1):116- 123.
  • 2Rivers E, Nguyen B, Hacstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng Med, 2001,346:1368-1377.
  • 3Pearse R, Dawson D, Fawcett J, et al. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomized,controlles trial [ISRC TN38797445]. Critical care,2005,9(6): R687-697.
  • 4Holgate ST.难治性哮喘.冯玉麟.刘春涛.译.北京:人民卫生出版社.2001.
  • 5Durham SR,Cookson WO,Faux J,et al.Basic mechanisms in allergen-induced late asthmatic responses. Clin Exp Allergy, 1989, 19: 117A.
  • 6Ten Hacken N, Kerstjens H, Postma D. Bronchiectasis[J/OL]. Clin Evid (Online), 2008:1507-1515.
  • 7Martinez Garcia MA, Perpina Tordera M, Roman Sanchez P, et al. In- ternal consistency and validity of the Spanish version of the St. George's respiratory questionnaire for use in patients with clinically stable bronchiectasis[J]. Arch Bronconeumol, 2005, 41(3): 110-117.
  • 8Kim DN, Lazarus AA. Management of bronchiectasis [J]. Dis Mon, 2008, 54(8): 540-546.
  • 9Bergin DA, Hurley K, Mehta A, et al. Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronehiectasis [J]. J Infiamm Res, 2013, 6:1-11.
  • 10Mandal P, Sidhu MK, Donaldson LS, et al. Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis [J]. QJM, 2013, 106 (1): 27-33.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部